packageCamizestrant

camizestrant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Camizestrant is an anti-estrogen drug being developed for the treatment of breast cancer. It is still investigational and not yet in routine use, though a positive regulatory opinion exists in the European Union.

Summary written by glm-5.3-flash from Wikidata Q124721211 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:camizestrant
ATC codes:L02BA05
DrugBank:DB19218
PubChem CID:134453496
Wikidata:Q124721211
formula:C24H28F4N6
molar mass:476.522 g/mol (PubChem CID 134453496)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown